22.4.2021
Cristiana Catella, Michele Camero, Maria Stella Lucente, Giuseppe Fracchiolla, Sabina Sblano, Maria Tempesta, Vito Martella, Canio Buonavoglia, Gianvito Lanave
Original article: Virucidal and antiviral effects of Thymus vulgaris essential oil on feline coronavirus
Basic facts
- EOs function as antibacterial, antiviral, antifungal and insecticidal agents.
- TEO has been shown to be effective against several RNA viruses, including CoV.
- The anti-infective activity of TEO against FCoV was assessed in CRFK cells.
- TEO has been shown to inhibit FCoV replication in vitro.
- TEO showed virucidal activity against FCoV up to 92,86%.
Abstract
Feline peritonitis (FIP) is a deadly systemic disease of cats caused by coronavirus (CoV) (FIPV). Despite their clinical significance and impact on cat health, therapeutic options for the treatment of FIP in cats are currently limited. The emergence of pandemic coronavirus severe respiratory syndrome type 2 (SARS-CoV-2), the etiological agent of coronavirus disease of 2019 (COVID-19), capable of infecting a wide range of animal species, including cats, has sparked interest in developing new molecules with antiviral activity to treat infections. CoV in humans and animals.
Essential oils (EOs) have attracted significant attention with their antiviral properties, which integrate and in some cases replace conventional drugs. Thymus vulgaris EO (TEO) is known to be effective against several RNA viruses, including CoV. In the present study, the antiviral activity of TEO against FIPV was evaluated in vitro.
TEO at a concentration of 27 μg / ml was able to inhibit virus replication with a significant reduction of 2 logs10 TCID50/ 50 μl. In addition, virucidal activity was tested by TEO at concentrations of 27 and 270 μg / ml, above the cytotoxic threshold, to determine a reduction in viral titer up to 3.25 log10 TCID50/ 50 μl within 1 hour of time contact. These results open up several perspectives in terms of future applications and therapeutic options for coronaviruses, as FIPV infection in cats could be a potential model for the study of antivirals against CoV.
keywords
Thyme essential oil, Cat coronavirus, Thymus vulgaris, Thyme, Thyme, Thyme, Thyme, FIP
The results
The 2019 coronavirus disease pandemic (COVID-19) caused by severe respiratory syndrome coronavirus (SARS-CoV-2) (WHO, 2020) stimulated research into treatment and immune prophylaxis using previous knowledge gathered on SARS-CoV-1 and animal CoV (Decaro et al., 2020). To date, no specific drug has been approved for the treatment of patients with COVID-19. However, remdesivir, an inhibitor of RNA-dependent RNA polymerase (RdRp), has shown promising results (Kabir et al., 2020). In addition, studies are currently underway to evaluate the efficacy of teicoplanin and monoclonal and polyclonal antibodies against SARS-CoV-2 (Kabir et al., 2020).
Drugs studied in cats for the treatment of feline infectious peritonitis (FIP) have also been tested against COVID-19 in human patients (Pedersen et al., 2018; Pedersen et al., 2019).
Coronaviruses have long been known for the existence of FIP, a deadly systemic disease in cats. FIP virus (FIPV) is a virulent pathotype of feline enteric coronavirus (FCoV) (Kummrow et al., 2005). Despite its impact on cat health, therapeutic options for the treatment of FIP in cats are limited and effective vaccines are not available. In addition, adverse effects of vaccines have been reported (Tizard, 2020). The development of new molecules with antiviral activity for the treatment of CoV infections is currently perceived as a priority in both human and animal medicine. FIPV infection in cats is considered a potential model for studying antiviral drugs against CoV (Amirian and Levy, 2020).
Herbal medicines have aroused the interest of both consumers and scientists (Hosseinzadeh et al., 2015) and essential oils (EO) extracted from aromatic and medicinal plants have increased special attention for their beneficial properties (de Sousa Barros et al., 2015). EOs have been reported to exhibit significant antiseptic, antibacterial, antiviral, antioxidant, antiparasitic, antifungal, and insecticidal effects (Chouhan et al., 2017; Ma and Yao, 2020). Recently, in catfish experimentally intoxicated with Thiamethoxam (TMX), administration of EO Thymus vulgaris (TEO) partially reduced the toxic effects of TMX (El Euony et al., 2020). EOs are also a potential reservoir of innovative therapeutic solutions that integrate and in some cases replace conventional drugs (Reichling et al., 2009). For example, EO Laurus nobilis (SARS-CoV-1) inhibited SARS CoV type 1 (SARS-CoV-1) (Loizzo et al., 2008) and the EO mixture was effective against avian coronavirus infectious bronchitis virus (IBV) (Jackwood et al. , 2010). ). EOs have also recently been shown to have antiviral activity against SARS-CoV-2 (Asif et al., 2020). TEO has been shown to be effective against several RNA viruses, including CoV (Lelešius et al., 2019; Nadi et al., 2020).
The composition of TEO (Specchiasol Bussolengo, Verona - Italy) was determined in three independent experiments by gas chromatography-mass spectrometry (GC-MS) (Rosato et al., 2020). Details on sample preparation, apparatus, and GC-MS analysis methods have already been published (Salvagno et al., 2020; Rosato et al., 2018). Data from GC / MS analyzes were expressed as % areas ± Structural Equation Modeling (SEM). In all cases, the SEM was less than 10%. Statistical analysis for SEM was performed using Microsoft Excel Office 2010 (Windows 7 Home Premium, Microsoft Corporation, USA). A total of 26 components were identified in the TEO sample, corresponding to 98.7% of the whole mixture. The detailed chemical composition of TEO is given in Additional Table 1.
TEO at a concentration of 928 mg / ml was first diluted in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, Missouri, USA) and then in Dulbecco-MEM (D-MEM).
Crandell Reese cat kidney cells (CRFK) were cultured in DMEM and strain FCoV-II 25/92 (Buonavoglia et al., 1995) with a titer of 105.25 TCID50/ 50 μl.
TEO cytotoxicity was assessed by XTT assay (Denizot and Lang, 1986) using the In Vitro Toxicology Assay Kit (Sigma - Aldrich Srl, Milan, Italy) after exposure of cells to various concentrations of compounds (7.25, 14.5, 29, 58, 116, 232 , 464, 928, 1856 μg / ml) for 72 hours. Cytotoxicity was evaluated by spectrophotometric measurement of the absorption signal (optical density, OD). In all experiments, untreated cells were used as a negative control for 0% cytotoxicity. Cells treated with equivalent dilutions of DMSO were used as a vehicle control. After logarithmic conversion of TEO concentrations, the data obtained in the cytotoxicity assays were analyzed using a non-linear curve fitting procedure. The accuracy of the match was tested by non-linear regression analysis of the dose-response curve. The maximum non-cytotoxic concentration was considered to be the concentration of compound at which the viability of treated CRFK cells decreased by no more than 20% (CC20) in view of the negative control.
CC value20 TEO was evaluated at 27 μg / ml and calculated based on the mean ± standard deviation (SD) from three experiments. In all experiments, DMSO showed no effect on cells.
Based on the results of the cytotoxicity test, the antiviral activity of TEO against the FCoV-II 25/92 strain was evaluated at 27 μg / ml and also below the cytotoxic threshold (13.5 μg / ml). Using a substance below the cytotoxic threshold allows us to reduce toxicity and achieve effective results at lower cost. Confluent CRFK cell monolayers 24 h in 24-well plates were infected with 100 μl FCoV-II containing 10,000 TCID50 with a multiplicity of infection (MOI) of 0.14. After virus adsorption for 1 hour at 37 ° C, the inocula were removed, the cell monolayers were washed once, and TEO was added. In untreated infected cells, D-MEM was used to replace the inoculum and used as a viral control. After 72 hours, aliquots of supernatants were taken for viral titration (Lanave et al., 2019) and RNA quantification (Gut et al., 1999).
The virucidal activity of TEO against FCoV-II was assessed by pre-treatment with the virus (10,000 TCID50) with TEO at a concentration of 27 μg / ml and above the cytotoxic threshold (270 μg / ml), because when used as a virucide, the molecule is not in direct contact with cells. Specifically, 100 μl of FCoV-II was treated with TEO (1 mL) at room temperature. Virus control was used for the experiments. After 10 minutes, 30 minutes, and 1 hour, aliquots of each virus-TEO and virus control mixture were subjected to virus titration (Lanave et al., 2019).
Data from antiviral and virucidal activity assays were expressed as mean ± SD and analyzed by analysis of variance (ANOVA) using Tukey's test as post hoc test (statistical significance set at 0.05).
Statistical analyzes were performed using GraphPad Prism v.8.0.0 software (GraphPad Software, San Diego, CA, USA).
Virus titers of TEO-treated CRFK cells and untreated infected cells (viral control) were expressed as log10 TCID50 / 50 μl and plotted against drug concentrations. By comparing the viral titer of untreated infected cells (4.25 log10 TCID50/ 50 μl) with infected TEO-treated cells at 13.5 and 27 μg / ml there was a decrease of 0.25 (p> 0.05) and 2.25 log10 TCID50/ 50 μl (p <0.0001), respectively (Fig. 1A). This suggests that TEO at a concentration of 27 μg / ml is able to significantly inhibit virus replication. The antiviral activity of TEO against FIPV corresponds to the results obtained with Thymus vulgaris hydrosols in vitro against swine reproductive and respiratory syndrome virus (PRRSV) (Kaewprom et al., 2017).

Viral titers were evaluated by endpoint dilution, expressed as log10 TCID50/ 50 μl and plotted against TEO at various concentrations (A). Viral nucleic acids were quantified by qPCR, expressed as log10 viral NA / 10ul and plotted against TEO at various concentrations (B). Bars in the figures indicate diameters. Error bars indicate standard deviation.
Viral nucleic acids (NA) were expressed as log10 viral NA / 10μl of infected cells treated with TEO and viral control and plotted against non-cytotoxic concentrations treated. By comparing the viral load of untreated infected cells (6.53 log10 viral NA / 10μl) with infected TEO-treated cells at 13.5 and 27 μg / ml, there was a decrease of 0.61 (p = 0.0005) and 1.34 (p <0.0001) log10 NAs / 10 μl, in that order (Figure 1B).
The virucidal activity of TEO was evaluated at different concentrations and for different contact times with FCoV-II (Fig. 2). After 10 minutes of TEO at 27 and 270 μg / ml, a reduction of 1.5 (p = 0.0008) and 2.5 (p <0.0001) log10 TCID50/ 50μl compared to virus control (4.25 log10 TCID50/ 50 μl) (Fig. 2A). After 30 minutes, TEO at 27 and 270 μg / ml induced a decrease of 1.25 (p = 0.0007) and 3.375 (p <0.0001) log10 TCID50/ 50 μl compared to virus control (3.75 log10 TCID50/ 50 μl) (Fig. 2B). After 1 hour of TEO at 27 and 270 μg / ml, there was a decrease of 1.25 (p = 0.0007) and 3.25 (p <0.0001) log10 TCID50/ 50μl compared to virus control (3.50 log10 TCID50/ 50μl). Viral inactivation occurred in a dose-time manner, starting at 33,33% and reaching 92,86%, when TEO was used at the highest concentration (270 μg / ml), after 1 hour (Fig. 2C). The virucidal activity of TEO can be explained by its ability to damage the viral envelope, thereby preventing adsorption and penetration into host cells (Reichling et al., 2009), as shown by electron microscopy of the herpesvirus envelope after pretreatment with EO (Shogan et al., 2006). TEO could therefore be a valuable means of disinfecting surfaces and could be an additive in the preparation of food products.

Thymus vulgaris is an aromatic plant of Mediterranean origin that contains EO and lipophilic substances (Nabavi et al., 2015) and its extracts are rich in thymol, carvacrol, p-cymene and γ-terpinene (Kowalczyk et al., 2020).
Thymus vulgaris has been shown to have antiviral activity against herpes simplex virus (HSV) (Nolkemper et al., 2006), influenza virus (Vimalanathan and Hudson, 2014), Newcastle disease virus (Rezatofighi et al., 2014), PRRSV (Kaewprom et al., 2017) and IBV (Lelešius et al., 2019), although the antiviral mechanism has yet to be elucidated. In contrast, inhibition of human immunodeficiency virus replication in vitro by TEO has been elucidated (Feriotto et al., 2018).
The chemical composition of TEO revealed the presence of 26 molecules, of which the main fractions were thymol, p-cymene, γ-terpinene, β-linalool, caryophyllene. To reduce the cytotoxicity of TEO, it would be interesting to identify active molecules and test them individually. As expected, the main component of TEO used in this study was thymol. The thymol fraction has been shown to be effective against HSV (Sharifi-Rad et al., 2017) and influenza virus (Alburn et al., 1972). Additional less abundant TEO fractions should be tested to evaluate their antiviral activity.
We demonstrated the in vitro antiviral and virucidal effect of TEO against FCoV in CRFK cells. These studies open up several perspectives in terms of future applications and therapeutic options for human and animal coronaviruses.
Declaration of conflict of interest
The authors declare that there is no conflict of interest.
Appendix A. Additional information
Table 1: Chemical composition of Thymus vulgaris essential oil
Number | Folder | Area% + SEM | SI / MS | LRI | AI |
---|---|---|---|---|---|
1 | propanoic acid, ethyl ester | 0.10+0.09 | 86 | 714 | 714 |
2 | α-tricyclene | 0.13+0.10 | 94 | 915 | 919 |
3 | α-thujene | 1.21+0.98 | 97 | 925 | 926 |
4 | α-pinene | 1.81+0.11 | 95 | 930 | 931 |
5 | camphene | 1.89+0.70 | 96 | 949 | 952 |
6 | 1-octen-3-ol | 0.37+0.01 | 83 | 974 | 975 |
7 | sabinene | 0.71+0.32 | 93 | 977 | 977 |
8 | β-pinene | 0.56+0.03 | 94 | 978 | 978 |
9 | β-myrcene | 1.42+0.25 | 86 | 985 | 991 |
10 | α-phellandrene | 0.15+0.01 | 91 | 1001 | 1003 |
11 | p-cymene | 19.64+2.50 | 95 | 1024 | 1024 |
12 | lemonade | 0.6+0.01 | 91 | 1033 | 1027 |
13 | eucalyptol | 0.89+0.07 | 99 | 1023 | 1031 |
14 | cis-β-terpineol | 0.13+0.01 | 90 | 1145 | 1147 |
15 | γ-terpinene | 8.83+0.87 | 94 | 1063 | 1059 |
16 | α-terpinolene | 0.12+0.01 | 81 | 1085 | 1089 |
17 | β-linalool | 4.07+1.55 | 97 | 1097 | 1098 |
18 | camphor | 1.69+0.77 | 98 | 1145 | 1146 |
19 | borneol | 1.85+0.98 | 97 | 1166 | 1167 |
20 | terpinen-4-ol | 1.83+0.89 | 96 | 1172 | 1174 |
21 | α-terpineol | 0.12+0.01 | 86 | 1189 | 1190 |
22 | methyl thymol, ether | 0.39+0.22 | 90 | 1235 | 1235 |
23 | isothymol methyl ether | 0.42+0.02 | 94 | ON THE | 1244 |
24 | thymol | 47.01+1.59 | 94 | 1290 | 1290 |
25 | caryophyllene | 2.18+0.99 | 99 | 1417 | 1418 |
26 | caryophyllene oxide | 0.58+0.13 | 91 | 1581 | 1592 |
Totally characterized | 98.7 | ||||
Others | 1.3 |
SEM = Structural Equation Modeling
SI / MS = Similarity Index / Mass Spectrum
LRI = Linear retention index
AI = Arithmetic Index
NA = not assessed
References
- Alburn et al., 1972
- HE Alburn, W. Chester, G. GreenspanThymol as an Anti-Influenza Agent(1972)U.S. Patent 3,632,782
- Amirian and Levy, 2020
- ES Amirian, JK LevyCurrent knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronavirusesOne Health, 9 (2020), p. 100128, 10.1016 / j.onehlt.2020.100128
- Asif et al., 2020
- M. Asif, M. Saleem, M. Saadullah, HS Yaseen, R. Al ZarzourCOVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory propertiesInflammopharmacology, 28 (2020), pp. 1153-1161, 10.1007 / s10787-020-00744-0
- Buonavoglia et al., 1995
- C. Buonavoglia, P. Sagazio, F. Cirone, M. Tempesta, F. MarsilioIsolation and characterization of a feline infectious peritonitis virus [Isolation and characterization of a feline infectious peritonitis strain]Veterinaria, 9 (1995), pp. 91-93
- Chouhan et al., 2017
- S. Chouhan, K. Sharma, S. GuleriaAntimicrobial activity of some essential oils-present status and future perspectivesMedicines (Basel)., 4 (2017), p. 58, 10.3390 / medicines4030058
- Decaro et al., 2020
- N. Decaro, V. Martella, LJ Saif, C. BuonavogliaCOVID-19 from veterinary medicine and one health perspectives: what animal coronaviruses have taught usRes. Vet. Sci., 131 (2020), pp. 21-23, 10.1016 / j.rvsc.2020.04.009
- Denizot and Lang, 1986
- F. Denizot, R. LangRapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliabilityJ. Immunol. Methods, 89 (1986), pp. 271-277, 10.1016/0022-1759(86)90368-6
- El Euony et al., 2020
- OI El Euony, SS Elblehi, HM Abdel-Latif, MM Abdel-Daim, YS El-SayedModulatory role of dietary Thymus vulgaris essential oil and Bacillus subtilis against thiamethoxam-induced hepatorenal damage, oxidative stress, and immunotoxicity in African catfish (Clarias garipenus)Environ. Sci. Pollut. Res. Int., 27 (2020), pp. 23108-23128, 10.1007 / s11356-020-08588-5
- Feriotto et al., 2018
- G. Feriotto, N. Marchetti, V. Costa, S. Beninati, F. Tagliati, C. MischiatiChemical composition of essential oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and their effects on the HIV-1 Tat protein functionChem. Biodivers., 15 (2018), p. 2, 10.1002 / cbdv.201700436
- Gut et al., 1999
- M. Gut, CM Leutenegger, JB Huder, NC Pedersen, H. LutzOne-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronavirusesJ. Virol. Methods, 77 (1999), pp. 37-46
- Hosseinzadeh et al., 2015
- S. Hosseinzadeh, A. Jafarikukhdan, A. Hosseini, R. ArmandThe application of medicinal plants in traditional and modern medicine: A review of Thymus vulgarisInt. J. Clin. Med., 6 (2015), pp. 635-642
- Jackwood et al., 2010
- MW Jackwood, R. Rosenbloom, M. Petteruti, DA Hilt, AW McCall, SM WilliamsAvian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivoVirus Res., 149 (2010), pp. 86-94, 10.1016 / j.virusres.2010.01.006
- Kabir et al., 2020
- MT Kabir, MS Uddin, MF Hossain, JA Abdulhakim, MA Alam, GM Ashraf, SG Bungau, MN Bin-Jumah, MM Abdel-Daim, L. AleyanCOVID-19 pandemic: from molecular pathogenesis to potential investigational therapeuticsFront. Cell Dev. Biol., 10 (2020), p. 616, 10.3389 / fcell.2020.00616
- Kaewprom et al., 2017
- K. Kaewprom, YH Chen, CF Lin, MT Chiou, CN LinAntiviral activity of Thymus vulgaris and Nepeta cataria hydrosols against porcine reproductive and respiratory syndrome virusThai. J. Vet. Med., 47 (2017), pp. 25-33
- Kowalczyk et al., 2020
- A. Kowalczyk, M. Przychodna, S. Sopata, A. Bodalska, I. FeckaThymol and thyme essential oil-new insights into selected therapeutic applicationsMolecules, 9 (2020), p. 4125, 10.3390 / molecules25184125
- Kummrow et al., 2005
- M. Kummrow, ML Meli, M. Haessig, E. Goenczi, A. Poland, NC Pedersen, R. Hofmann-Lehmann, H. LutzFeline coronavirus serotypes 1 and 2: seroprevalence and association with disease in SwitzerlandClin. Diagn. Lab. Immunol., 12 (2005), pp. 1209-1215, 10.1128 / CDLI.12.10.1209-1215.2005
- Lanave et al., 2019
- G. Lanave, MS Lucente, P. Siciliano, C. Zizzadoro, P. Trerotoli, V. Martella, C. Buonavoglia, M. Tempesta, M. Camero.Antiviral activity of PHA767491 on caprine alphaherpesvirus 1 in vitroRes. Vet. Sci., 126 (2019), pp. 113-117, 10.1016 / j.rvsc.2019.08.019
- Lelešius et al., 2019
- R. Lelešius, A. Karpovaitė, R. Mickienė, T. Drevinskas, N. Tiso, O. Ragažinskienė, L. Kubilienė, A. Maruška, A. ŠalomskasIn vitro antiviral activity of fifteen plant extracts against avian infectious bronchitis virusBMC Vet. Res., 29 (2019), p. 178, 10.1186 / s12917-019-1925-6
- Loizzo et al., 2008
- MR Loizzo, AM Saab, R. Tundis, GA Statti, F. Menichini, I. Lampronti, R. Gambari, J. Cinatl, HW Doerr.Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon speciesChem. Biodivers., 5 (2008), pp. 461-470, 10.1002 / cbdv.200890045
- Ma and Yao, 2020
- L. Ma, L. YaoAntiviral effects of plant-derived essential oils and their components: an updated reviewMolecules, 5 (2020), p. 2627, 10.3390 / molecules25112627
- Nabavi et al., 2015
- SM Nabavi, A. Marchese, M. Izadi, V. Curti, M. Daglia, SF NabaviPlants belonging to the genus Thymus as antibacterial agents: from farm to pharmacyFood Chem., 173 (2015), pp. 339-347
- Nadi et al., 2020
- A. Nadi, A. Abbas Shiravi, Z. Mohammadi, A. Aslani, M. ZeinalianThymus vulgaris, a natural pharmacy against COVID-19 and other similar infections: a molecular reviewZenodo (2020), 10.5281 / zenodo.3841889
- Nolkemper et al., 2006
- S. Nolkemper, J. Reichling, FC Stintzing, R. Carle, P. SchnitzlerAntiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitroPlanta Med., 72 (2006), pp. 1378-1382, 10.1055 / s-2006-951719
- Pedersen et al., 2018
- NC Pedersen, Y. Kim, H. Liu, AC Galasiti Kankanamalage, C. Eckstrand, WC Groutas, M. Bannasch, JM Meadows, KO Chang.Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitisJ. Feline Med. Surg., 20 (2018), pp. 378-392, 10.1177 / 1098612X17729626
- Pedersen et al., 2019
- NC Pedersen, M. Perron, M. Bannasch, E. Montgomery, E. Murakami, M. Liepnieks, H. LiuEfficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitisJ. Feline Med. Surg., 21 (2019), pp. 271-281, 10.1177 / 1098612X19825701
- Reichling et al., 2009
- J. Reichling, P. Schnitzler, U. Suschke, R. SallerEssential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties – an overviewForsch Komplementmed, 16 (2009), pp. 79-90, 10.1159/000207196
- Rezatofighi et al., 2014
- SE Rezatofighi, A. Seydabadi, SM Seyyed NejadEvaluating the efficacy of Achillea millefolium and Thymus vulgaris extracts against newcastle disease virus in ovoJundishapur J. Microbiol., 7 (2014), Article e9016, 10.5812 / jjm.9016
- Rosato et al., 2018
- A. Rosato, A. Carocci, A. Catalano, ML Clodoveo, C. Franchini, F. Corbo, GG Carbonara, A. Carrieri, G. FracchiollaElucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobialsPLoS One, 13 (2018), Article e0200902, 10.1371 / journal.pone.0200902
- Rosato et al., 2020
- A. Rosato, S. Sblano, L. Salvagno, A. Carocci, ML Clodoveo, F. Corbo, G. FracchiollaAnti-biofilm inhibitors synergistic effects of combinations of essential oils and antibioticsAntibiotics (Basel), 9 (2020), p. 637, 10.3390 / antibiotics9100637
- Salvagno et al., 2020
- GL Salvagno, E. Danese, G. LippiMass spectrometry and total laboratory automation: opportunities and drawbacksClin. Chem. Lab. Med., 58 (2020), pp. 994-1001, 10.1515 / cclm-2019-0723
- Sharifi-Rad et al., 2017
- J. Sharifi-Rad, B. Salehi, P. Schnitzler, SA Ayatollahi, F. Kobarfard, M. Fathi, M. Eisazadeh, M. Sharifi-RadSusceptibility of herpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oils of Sinapis arvensis L., Lallemantia royleana Benth. and Pulicaria vulgaris GaertnCell Mol. Biol. (Noisy-le-grand), 30 (2017), pp. 42-47, 10.14715 / cmb / 2017.63.8.10
- Shogan et al., 2006
- B. Shogan, L. Kruse, GB Mulamba, A. Hu, DM CoenVirucidal activity of a GT rich oligonucleotide against herpes simplex virus mediated by glycoprotein BJ. Virol., 80 (2006), pp. 4740-4747
- of Sousa Barros et al., 2015
- A. de Sousa Barros, SM de Morais, PAT Ferreira, Í.GP Vieira, AA Craveiro, RO dos Santos Fontenelle, JESA de Menezes, FWF da Silva, HA de SousaChemical composition and functional properties of essential oils from Mentha speciesInd. Crop. Prod., 76 (2015), pp. 557-564, 10.1016 / j.indcrop.2015.07.004
- Tizard, 2020
- IR TizardVaccination against coronaviruses in domestic animalsVaccine, 38 (2020), pp. 5123-5130, 10.1016 / j.vaccine.2020.06.026
- Vimalanathan and Hudson, 2014
- S. Vimalanathan, J. HudsonAnti-influenza virus activity of essential oils and vaporsAm. J. Essent Oil, 2 (2014), pp. 47-53
- World Health Organization (WHO), 2020
- World Health Organization (WHO)Coronavirus Disease (COVID-19) Pandemic